Daniel M. Geynisman
机构：Fox Chase Cancer Center
发表论文 8 篇 · 总被引 9 次 · h-index 1
代表论文
- Circulating tumor DNA (ctDNA) to guide response-adapted bladder preservation in muscle invasive bladder cancer (MIBC): Integrated analysis of the RETAIN trials. (2026 · Journal of Clinical Oncology · 被引 9)
- Pathologic response after neoadjuvant therapy in renal cell carcinoma using irRVT criteria. (2026 · Journal of Clinical Oncology)
- Circulating tumor DNA analysis from the prospective pT0 study of systematic endoscopic evaluation in patients undergoing radical cystectomy for bladder cancer. (2026 · Journal of Clinical Oncology)
- Assessing the impact of cardiovascular disease and ADT on survival disparities in prostate cancer. (2026 · Journal of Clinical Oncology)
- A phase 2 study of gemcitabine plus carboplatin as second-line therapy after prior enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma. (2026 · Journal of Clinical Oncology)
- Clinical outcomes of metastatic urothelial carcinoma patients discontinuing enfortumab vedotin due to toxicity and/or clinical response. (2026 · Journal of Clinical Oncology)